Compare Amylx Pharmaceuticals Inc (AMLX) vs Braze Inc (BRZE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs Braze Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Braze Inc trades at $27.77 (market cap $3.18B). The key difference: Braze Inc is the larger of the two by market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, Braze Inc nearer its low. Which is the better fit depends on your goals.
| AMLX | BRZE | |
|---|---|---|
Market Cap | $2.64B | $3.18B |
Sector | Health | Technology |
52-Week High | $24.19 | $36.19 |
52-Week Low | $7.82 | $15.79 |
Enterprise Value | $2.39B | $2.87B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About Braze Inc
Braze Inc is a customer engagement platform that powers customer-centric interactions between consumers and brands. The company provides solutions for Retail & E-commerce, Media & Entertainment, Financial Services, and Travel & Hospitality related industries.
Read more on BRZE →
